<DOC>
	<DOCNO>NCT02814110</DOCNO>
	<brief_summary>Importance : Currently gold standard treatment ambulant patient corticosteroid . Granulocyte colony-stimulating factor ( G-CSF ) report exert proliferation satellite cell , regulation myoblast proliferation , differentiation promotion muscle regeneration repair . Objectives To evaluate safety efficacy G-CSF child adolescent muscular dystrophy Duchenne muscular dystrophy , Becker muscular dystrophy , Fascioscapulohumeral dystrophy . Design , Setting , Participants : Patients age 5-15 diagnosed muscular dystrophy include open study . Patients wheelchair-bound mobile self-independent participate study . Patients also treat steroid participate study . Clinical examination physiotherapeutic laboratory test perform . G-CSF ( 5mcg/kg/body/d ) give subcutaneously five consecutive day 1st , 2nd , 3rd . 6th 12th month . Manual muscle test ( Lovett test ) upper low extremity , isometric force hand dynamometer , 6MWT ( six minute walk test ) measure therapy .</brief_summary>
	<brief_title>Efficacy Safety Granulocyte Colony-stimulating Factor Treatment Children Adolescents With Muscular Dystrophy</brief_title>
	<detailed_description>Importance : Currently gold standard treatment ambulant patient corticosteroid . Granulocyte colony-stimulating factor ( G-CSF ) report exert proliferation satellite cell , regulation myoblast proliferation , differentiation promotion muscle regeneration repair . Objectives To evaluate safety efficacy G-CSF child adolescent muscular dystrophy Duchenne muscular dystrophy , Becker muscular dystrophy , Fascioscapulohumeral dystrophy . Design , Setting , Participants : Patients age 5-15 diagnosed muscular dystrophy include open study . Patients wheelchair-bound mobile self-independent participate study . Patients also treat steroid participate study . Clinical examination physiotherapeutic laboratory test perform . G-CSF ( 5mcg/kg/body/d ) give subcutaneously five consecutive day 1st , 2nd , 3rd . 6th 12th month . Blood sample G-CSF administration 5th day treatment cycle . During cycle G-CSF administration physical therapy also apply . Abdominal ultrasonography spleen assessment perform 7 day G-CSF administration . Spirometry electrocardiographic record also perform . Side effect G-CSF treatment assess . Manual muscle test ( Lovett test ) upper low extremity , isometric force hand dynamometer , 6MWT ( six minute walk test ) measure therapy . MRI gastrocnemius muscle perform begin end therapy .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Muscular dystrophy Duchenne muscular dystrophy , Becker muscular dystrophy , Fascioscapulohumeral dystrophy age 515 non muscular dystrophy age 5 year age 15 year</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Granulocyte colony-stimulating factor</keyword>
	<keyword>muscular dystrophy</keyword>
	<keyword>muscle strength</keyword>
	<keyword>child</keyword>
	<keyword>adolescent</keyword>
</DOC>